Literature DB >> 26697732

Parry-Romberg syndrome: a case with a possible association with Lyme disease.

Nicola di Meo1, Giuseppe Stinco2, Katiuscia Nan3, Caterina Pinzani2, Giusto Trevisan1.   

Abstract

Parry-Romberg syndrome is an acquired slowly progressive disease characterized by an atrophy mostly involving half of the face. The pathogenesis of this disfiguring condition is still controversial. The relationship between Parry-Romberg syndrome and Lyme disease needs to be considered in depth. A 16-year-old woman from Albania presented with linear depressions of the right side of the face, clinically compatible with Parry-Romberg syndrome. She had a positive history of Lyme disease. Borrelia infection was confirmed by the positivity of PCR and the presence of IgM antibodies. The patient received intravenous penicillin and metronidazole for 14 days. After treatment and during a 2-year follow-up, the clinical disease progression was halted and the serological and microbiological tests for Borrelia burgdorferi sensu lato were negative. We cannot exclude a coincidence, however, of the bacteriological and serological evidence. Moreover, the interruption of the disease progression after the antibiotic therapy is difficult to ignore without claiming that this association is at least suggestive.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26697732

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  3 in total

Review 1.  Progressive Hemifacial Atrophy and Linear Scleroderma En Coup de Sabre: A Spectrum of the Same Disease?

Authors:  Irina Khamaganova
Journal:  Front Med (Lausanne)       Date:  2018-01-31

2.  Lower limb onset Parry-Romberg syndrome: an unusual presentation of a rare disease.

Authors:  Rajendra Singh Jain; Sunil Kumar; Trilochan Srivastava
Journal:  Oxf Med Case Reports       Date:  2016-08-29

3.  Serological evidence of possible Borrelia afzelii lyme disease in Greece.

Authors:  I Karageorgou; M Koutantou; I Papadogiannaki; A Voulgari-Kokota; S Makka; E Angelakis
Journal:  New Microbes New Infect       Date:  2022-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.